medigraphic.com
ISSN 2954-3835 (Digital)
ISSN 2683-2828 (Impreso)

2025, Número 3

Siguiente >>

Cardiovasc Metab Sci 2025; 36 (3)


En busca de una definición operativa y científica de la obesidad, una amenaza multifacética y compleja para la salud mundial

López-Dionicio YI, Lara-Padilla E, Guevara G, Amador-Jara DI, García-Rodríguez J, Martínez-Quintero F, Nájera N, Ceballos G, Meaney E

Idioma: Inglés [English version]
Referencias bibliográficas: 48
Paginas: 133-141
Archivo PDF: 373.33 Kb.





REFERENCIAS (EN ESTE ARTÍCULO)

  1. Micic D, Polovina S, Micic D, Yumuk VD. Short history of obesity. Acta Endocrinol (Buchar). 2025; 20: 207-211. doi: 10.4183/aeb.2024.207.

  2. González-González JJ, Sanz-Álvarez L, García Bernardo C. La obesidad en la historia de la cirugía. Cir Esp. 2008; 84: 188-195. doi: 10.1016/S0009-739X(08)72618-6.

  3. Papavramidou NS, Papavramidis ST, Christopoulou-Aletra H. Galen on obesity: etiology, effects, and treatment. WJS. 2004; 28: 631-635. doi: 10.1007/s00268-004-7458-5.

  4. Komaroff M. For researchers on obesity: Historical review of extra body weight definitions. J Obes. 2016; 2016: 2460285. doi: 10.1155/2016/2460285.

  5. Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. J Chronic Dis. 1972; 25: 329-343. doi: 10.1016/0021-9681(72)90027-6.

  6. World Health Organization. Obesity and overweight. Overview [Internet]. Geneva: World Health Organization; 2025. Available in: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

  7. World Health Organization. Physical status: the use and interpretation of anthropometry: report of a WHO Expert Committee [Internet]. Geneva: World Health Organization; 1995 (WHO Technical Report Series; No. 854). Available in: https://apps.who.int/iris/handle/10665/37003

  8. Purnell JQ. Definitions, classification, and epidemiology of obesity. In: Feingold KR, Ahmed SF, Anawalt B, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. Available in: https://www.ncbi.nlm.nih.gov/books/NBK279167/

  9. Caleyachetty R, Barber TM, Mohammed NI, Cappuccio FP, Hardy R, Mathur R et al. Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2021; 9: 419-426. doi: 10.1016/S2213-8587(21)00088-7.

  10. Meaney E, Fernández Barros CL, Enciso Muñoz JM, Ceballos Reyes G, Nájera N, León Hernández FJ et al. The attempt to demolish the science and practice of preventive cardiovascular medicine. Part I. Rev Mex Cardiol. 2018; 29: 173-187.

  11. Pray R, Riskin S. The history and faults of the Body Mass Index and where to look next: A literature review. Cureus. 2023; 15: e48230. doi: 10.7759/cureus.48230.

  12. Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, MagniP et al. Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR Working Group on visceral obesity. Nat Rev Endocrinol. 2020; 16: 177-189. doi: 10.1038/s41574-019-0310-7.

  13. Wu Y, Li D, Vermund SH. Advantages and limitations of the Body Mass Index (BMI) to assess adult obesity. Int J Environ Res Public Health. 2024; 21: 757. doi: 10.3390/ijerph21060757.

  14. Nowak MM, Niemczyk M, Go??biewski S, Paczek L. Impact of Body Mass Index on all-cause mortality in adults: A systematic review and meta-analysis. J Clin Med. 2024; 13: 2305. doi: 10.3390/jcm13082305.

  15. Pandey A, Patel KV, Vaduganathan M, Sarma S, Haykowsky MJ, Berry JD et al. Physical activity, fitness, and obesity in heart failure with preserved ejection fraction. JACC Heart Fail. 2018; 6: 975-982. doi: 10.1016/j.jchf.2018.09.006.

  16. Gray N, Picone G, Sloane F, Tashkin A. The relationship between BMI and onset of diabetes mellitus and its complications. South Med J. 2015; 108: 29-36. doi: 10.14423/SMJ.0000000000000214.

  17. Asztalos BF, Russo G, He L, Diffenderfer MR. Body Mass Index and cardiovascular risk markers: An extensive population analysis. Nutrients. 2025; 17: 740. doi: 10.3390/nu17050740.

  18. Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009; 373: 1083-1096. doi: 10.1016/S0140-6736(09)60318-4.

  19. Janssen I, Mark AE. Elevated body mass index and mortality risk in the elderly. Obes Rev. 2007; 8: 41-59. doi: 10.1111/j.1467-789X.2006.00248.x.

  20. Asia Pacific Cohort Studies Collaboration. Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol. 2004; 33: 751-758. doi: 10.1093/ije/dyh163.

  21. Heydari ST, Ayatollahi SMT, Zare N. Diagnostic value of bioelectrical impedance analysis versus body mass index for detection of obesity among students. Asian J Sports Med. 2011; 2: 68-74. doi: 10.5812/asjsm.34777.

  22. Reinert BL, Pohlman R, Hartzler L. Correlation of Air Displacement Plethysmography with alternative Body Fat Measurement techniques in men and women. Int J Exerc Sci. 2012; 5: 367-378. doi: 10.70252/IKWZ5306.

  23. Meaney E, Pérez-Robles E, Ortiz-Flores M, Perez-Ishiwara G, Meaney A, Munguía L et al. Obesity, and age are the main determinants of cardiovascular risk aggregation in the current Mexican population: The FRIMEX III study. J Clin Med. 2024; 13: 2248. doi: 10.3390/jcm13082248.

  24. Barquera S, Campos-Nonato I, Hernández-Barrera L, Flores M, Durazo-Arvizu R, Kanter R et al. Obesity and central adiposity in Mexican adults: results from the Mexican National Health and Nutrition Survey 2006. Salud Publica Mex. 2009; 51 suppl 4: S595-S603.

  25. Potter AW, Chin GC, Looney DP, Friedl KE. Defining overweight and obesity by percent body fat instead of Body Mass Index. J Clin Endocrinol Metab. 2025; 110: e1103-e1107. doi: 10.1210/clinem/dgae341.

  26. Jackson AS, Pollock ML. Generalized equations for predicting body density of men. Br J Nutr. 1978; 40: 497-504. doi: 10.1079/bjn19780152.

  27. Jackson AS, Pollock ML, Ward A. Generalized equations for predicting body density of women. Med Sci Sports Exerc. 1980; 12: 175-181.

  28. Hatta H, Iwaoka K, Atomi Y. Measure human body density by underwater weighing method with or without maximum exhalation. J-STAGE. 1997; 1: 237-239. doi: 10.32226/jjbse.1997_01.

  29. Bijlsma A, van Beijsterveldt IALP, Vermeulen MJ, Beunders VAA, Dorrepaal DJ, Boeters SCM et al. Challenges in body composition assessment using air-displacement plethysmography by BOD POD in pediatric and young adult patients. Clin Nutr. 2023; 42 (9): 1588-1594. doi: 10.1016/j.clnu.2023.07.003.

  30. Messina C, Albano D, Gitto S, Tofanelli L, Bazzocchi A, Uluvieri FM et al. Body composition with dual energy X-ray absorptiometry: from basics to new tools. Quant Imaging Med Surg. 2020; 10: 1687-1698. doi: 10.21037/qims.2020.03.02.

  31. Wells J. The limitations of DXA for body composition assessment. Endocr Abstr. 2009; 19: S78.

  32. Khalil SF, Mohkta MS, Ibrahim F. The theory and fundamentals of bioimpedance analysis in clinical status monitoring and diagnosis of diseases. Sensors (Basel). 2014; 14: 10895-10928. doi: 10.3390/s140610895.

  33. Hoffer EC, Meador CK, Simpson DC. Correlation of whole-body impedance with total body water volume. J Appl Physiol. 1969; 27: 531-534. doi: 10.1152/jappl.1969.27.4.531.

  34. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM et al. Bioelectrical impedance analysis-Part 1: Review of principles and methods. Clin Nutr. 2004; 23: 1226-1243. doi: 10.1016/j.clnu.2004.06.004.

  35. Chumlea WC, Guo SS. Bioelectrical impedance and body composition: Present status and future directions. Nutr Rev. 1994; 52: 123-131. doi: 10.1111/j.1753-4887.1994.tb01404.x.

  36. Willett K, Jiang R, Lenart E, Spiegelman D, Willett W. Comparison of bioelectrical impedance and BMI in predicting obesity-related medical conditions. Obesity. 2012; 14: 480-490. doi: 10.1038/oby.2006.63.

  37. Heydari ST, Ayatollahi SMT, Zare N. Op. cit. Reference 21. Diagnostic value of bioelectrical impedance analysis versus body mass index for detection of obesity among students. Asian J Sports Med. 2011; 2: 68-74. doi: 10.5812/asjsm.34777.

  38. Sun G, French CR, Martin GR, Younghusband B, Green RC, Xie Y et al. Comparison of multifrequency bioelectrical impedance analysis with dual-energy X-ray absorptiometry for assessment of percentage body fat in a large, healthy population. Am J Clin Nutr. 2005; 81: 74-78. doi: 10.1093/ajcn/81.1.74.

  39. Muniyandi M, Sellappan S, Chellaswamy V, Ravi K, Karthikeyan S, Thiruvengadam K et al. Diagnostic accuracy of mercurial versus digital blood pressure measurement devices: a systematic review and meta-analysis. Sci Rep. 2022; 12: 3363. doi: 10.1038/s41598-022-07315-z.

  40. Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025; 13: 221-262. doi: 10.1016/S2213-8587(24)00316-4.

  41. Kim MJ, Jung CH. Toward precision in obesity diagnosis: Progress, pitfalls, and the path ahead. J Obes Metab Syndr. 2025; 34: 85-87. doi: 10.7570/jomes25032.

  42. Fanghanel-Salmón G, Gutiérrez-Salmeán G, Samaniego V, Meaney A, Sánchez-Reyes L, Navarrete U et al. Obesity phenotypes in urban middle-class cohorts; the PRIT-Lindavista merging evidence in Mexico: the OPUS PRIME study. Nutr Hosp. 2015; 32 (1): 182-188.

  43. Akinci B, Gular MC, Oral EA. Lipodystrophy syndromes: presentation and treatment. In: Feingold KR, Ahmed SF, Anawalt B et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. Available in: https://www.ncbi.nlm.nih.gov/books/NBK513130/

  44. Phan J, Reue K. Lipin, a lipodystrophy and obesity gene. Cell Metab. 2005; 1: 73-83. doi: 10.1016/j.cmet.2004.12.002.

  45. Allison DB, Downey M, Atkinson RL, Billington CJ, Bray GA, Eckel RH et al. Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity (Silver Spring). 2008; 16 (6): 1161-1177. doi: 10.1038/oby.2008.231.

  46. Heshka S, Allison DB. Is obesity a disease? Int J Obes. 2001; 25: 1401-1404. doi: 10.1038/sj.ijo.0801790.

  47. Buysschaert I, Schmidt T, Roncal C, Carmeliet P, Lambrechts D. Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis. J Cell Mol Med. 2008; 12: 2533-2551. doi: 10.1111/j.1582-4934.2008.00515.x.

  48. Kohlwein SD. Obese and anorexic yeasts: experimental models to understand the metabolic syndrome and lipotoxicity. Biochim Biophys Acta. 2010; 1801 (3): 222-229. doi: 10.1016/j.bbalip.2009.12.016.




2020     |     www.medigraphic.com